These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31872649)

  • 1. [Research progress on triptolide functionalized nanoparticulate drug delivery systems for tumor treatment].
    Luo YY; Shi JF; Chen L; Li JX; Ma XY; Zhang JM; Geng FN
    Zhongguo Zhong Yao Za Zhi; 2019 Nov; 44(21):4566-4572. PubMed ID: 31872649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triptolide-targeted delivery methods.
    Xu H; Liu B
    Eur J Med Chem; 2019 Feb; 164():342-351. PubMed ID: 30605832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of triptolide: a combination of traditional Chinese medicine and nanomedicine.
    Sun R; Dai J; Ling M; Yu L; Yu Z; Tang L
    J Nanobiotechnology; 2022 Apr; 20(1):194. PubMed ID: 35443712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triptolide delivery: Nanotechnology-based carrier systems to enhance efficacy and limit toxicity.
    Ren Q; Li M; Deng Y; Lu A; Lu J
    Pharmacol Res; 2021 Mar; 165():105377. PubMed ID: 33484817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamer-functionalized triptolide with release controllability as a promising targeted therapy against triple-negative breast cancer.
    Chen Y; Yang J; Wang C; Wang T; Zeng Y; Li X; Zuo Y; Chen H; Zhang C; Cao Y; Sun C; Wang M; Cao X; Ge X; Liu Y; Zhang G; Deng Y; Peng C; Lu A; Lu J
    J Exp Clin Cancer Res; 2024 Jul; 43(1):207. PubMed ID: 39054545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Delivery and Sustained Antitumor Activity of Triptolide through Glucose Conjugation.
    He QL; Minn I; Wang Q; Xu P; Head SA; Datan E; Yu B; Pomper MG; Liu JO
    Angew Chem Int Ed Engl; 2016 Sep; 55(39):12035-9. PubMed ID: 27574181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential delivery of nanoformulated α-mangostin and triptolide overcomes permeation obstacles and improves therapeutic effects in pancreatic cancer.
    Feng J; Xu M; Wang J; Zhou S; Liu Y; Liu S; Huang Y; Chen Y; Chen L; Song Q; Gong J; Lu H; Gao X; Chen J
    Biomaterials; 2020 May; 241():119907. PubMed ID: 32120315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of triptolide-nanoemulsion gels for percutaneous administration: physicochemical, transport, pharmacokinetic and pharmacodynamic characteristics.
    Yang M; Gu Y; Yang D; Tang X; Liu J
    J Nanobiotechnology; 2017 Dec; 15(1):88. PubMed ID: 29202753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, characterization and in vitro evaluation of triptolide-lysozyme conjugate for renal targeting delivery of triptolide.
    Zheng Q; Gong T; Sun X; Zhang ZR
    Arch Pharm Res; 2006 Dec; 29(12):1164-70. PubMed ID: 17225468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research progress on anti-tumor effects and mechanisms of triptolide and its combined application].
    Shi JF; Luo YY; Li JX; Luo RF; Chen L; Li J; Zhang JM; Fu CM
    Zhongguo Zhong Yao Za Zhi; 2019 Aug; 44(16):3391-3398. PubMed ID: 31602900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research progress of triptolide-loaded nanoparticles delivery systems.
    Xiong FL; Chen HB; Chang XL; Yang YJ; Xu HB; Yang XL
    Conf Proc IEEE Eng Med Biol Soc; 2005; 2005():4966-9. PubMed ID: 17281359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acupoint nanocomposite hydrogel for simulation of acupuncture and targeted delivery of triptolide against rheumatoid arthritis.
    Ren S; Liu H; Wang X; Bi J; Lu S; Zhu C; Li H; Kong W; Chen R; Chen Z
    J Nanobiotechnology; 2021 Dec; 19(1):409. PubMed ID: 34876139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triptolide: progress on research in pharmacodynamics and toxicology.
    Li XJ; Jiang ZZ; Zhang LY
    J Ethnopharmacol; 2014 Aug; 155(1):67-79. PubMed ID: 24933225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-sensitive nanoformulated triptolide as a targeted therapeutic strategy for hepatocellular carcinoma.
    Ling D; Xia H; Park W; Hackett MJ; Song C; Na K; Hui KM; Hyeon T
    ACS Nano; 2014 Aug; 8(8):8027-39. PubMed ID: 25093274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and anti-inflammatory activity of triptolide ethosomes in an erythema model.
    Chen JG; Liu YF; Gao TW
    J Liposome Res; 2010 Dec; 20(4):297-303. PubMed ID: 20102297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nano Traditional Chinese Medicine: Current Progresses and Future Challenges.
    Huang Y; Zhao Y; Liu F; Liu S
    Curr Drug Targets; 2015; 16(13):1548-62. PubMed ID: 25751006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic dendrimer delivery of triptolide to tumor-associated macrophages improves anti-tumor efficacy and reduces systemic toxicity in glioblastoma.
    Liaw K; Sharma R; Sharma A; Salazar S; Appiani La Rosa S; Kannan RM
    J Control Release; 2021 Jan; 329():434-444. PubMed ID: 33290796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triptolide: Medicinal chemistry, chemical biology and clinical progress.
    Hou W; Liu B; Xu H
    Eur J Med Chem; 2019 Aug; 176():378-392. PubMed ID: 31121546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms.
    Zhang YQ; Shen Y; Liao MM; Mao X; Mi GJ; You C; Guo QY; Li WJ; Wang XY; Lin N; Webster TJ
    Nanomedicine; 2019 Jan; 15(1):86-97. PubMed ID: 30244085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triptolide loaded solid lipid nanoparticle hydrogel for topical application.
    Mei Z; Wu Q; Hu S; Li X; Yang X
    Drug Dev Ind Pharm; 2005 Jan; 31(2):161-8. PubMed ID: 15773283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.